Form 8-K - Current report:
SEC Accession No. 0000950170-23-019631
Filing Date
2023-05-09
Accepted
2023-05-09 16:07:39
Documents
13
Period of Report
2023-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20230509.htm   iXBRL 8-K 58660
2 EX-99.1 allk-ex99_1.htm EX-99 184827
  Complete submission text file 0000950170-23-019631.txt   371314

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20230509_pre.xml EX-101.PRE 9898
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20230509_lab.xml EX-101.LAB 13474
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20230509.xsd EX-101.SCH 2466
7 EXTRACTED XBRL INSTANCE DOCUMENT allk-20230509_htm.xml XML 4741
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

EIN.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 23901975
SIC: 2834 Pharmaceutical Preparations